For: | Lynch EN, Campani C, Innocenti T, Dragoni G, Biagini MR, Forte P, Galli A. Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives. World J Hepatol 2022; 14(6): 1111-1119 [PMID: 35978669 DOI: 10.4254/wjh.v14.i6.1111] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v14/i6/1111.htm |
Number | Citing Articles |
1 |
Zobair M. Younossi, Andreas E. Kremer, Mark G. Swain, David Jones, Christopher Bowlus, Michael Trauner, Linda Henry, Lynn Gerber. Assessment of fatigue and its impact in chronic liver disease. Journal of Hepatology 2024; doi: 10.1016/j.jhep.2024.04.008
|
2 |
Atsushi Tanaka. New Therapies on the Horizon for Primary Biliary Cholangitis. Drugs 2024; 84(1): 1 doi: 10.1007/s40265-023-01979-1
|
3 |
Kathryn Jack, Palle Bager. Research round-up. Gastrointestinal Nursing 2023; 21(Sup1): S6 doi: 10.12968/gasn.2023.21.Sup1.S6
|
4 |
Asma Faisal. Understanding fatigue and pruritus in primary biliary cholangitis. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000216
|
5 |
Palle Bager, Lars Bossen, Rasmus Gantzel, Henning Grønbæk, Wan-Long Chuang. High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial. PLOS ONE 2024; 19(3): e0301354 doi: 10.1371/journal.pone.0301354
|
6 |
Ju Zou, Jie Li, Xiaoxu Wang, Daolin Tang, Ruochan Chen. Neuroimmune modulation in liver pathophysiology. Journal of Neuroinflammation 2024; 21(1) doi: 10.1186/s12974-024-03181-w
|
7 |
Mariana Zapata, Hendrick Pagan-Torres, Marlyn J. Mayo. Systemic Complications of Primary Biliary Cholangitis. Clinics in Liver Disease 2024; 28(1): 115 doi: 10.1016/j.cld.2023.07.004
|
8 |
Torbjörn Bäckström, Magnus Doverskog, Thomas P. Blackburn, Bruce F. Scharschmidt, Vicente Felipo. Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment. Neuroscience & Biobehavioral Reviews 2024; 161: 105668 doi: 10.1016/j.neubiorev.2024.105668
|